Show: 1 day 1 week 1 month All
Custom (decided): –
Coverage since February 25, 2025
✉️ New decisions, briefed in your inbox every morning — subscribe to Daily Case Law, free →

European Union

Unified Patent Court, Court of Appeal
Uncategorized

Fujifilm v. Kodak — UPC Court of Appeal Issues Landmark Ruling on Long-Arm Jurisdiction Over Non-Member States

The UPC Court of Appeal ruled that the Unified Patent Court can accept jurisdiction over patent infringement in non-member states like the UK, but overturned a Mannheim injunction on substantive grounds — establishing a three-category framework for managing long-arm claims.

Court of Justice of the European Union (Grand Chamber)
Uncategorized

CJEU Grand Chamber: Meta Must Compensate Press Publishers for News Snippets Under EU Copyright Directive

The Court of Justice of the European Union ruled in a Grand Chamber decision that online platforms like Meta must provide fair compensation to press publishers when displaying snippets or previews of news articles, clarifying the scope of the EU Copyright Directive (2019/790).

Unified Patent Court, Local Division Düsseldorf
Uncategorized

Align Technology v. Angelalign — UPC Düsseldorf Denies Preliminary Injunction on Clear Aligner Patent, Requires Feature-by-Feature Technical Proof

The Unified Patent Court’s Düsseldorf Local Division denied Align Technology’s application for provisional measures against Chinese competitor Angelalign, ruling that promotional materials alone cannot establish patent infringement without independent technical analysis.

Unified Patent Court, Central Division (Milan)
Uncategorized

Gilead Sciences v. Academy of Military Medical Sciences — UPC Revokes Chinese Military Institute’s Remdesivir COVID-19 Patent for Lack of Inventive Step

The UPC Central Division in Milan revoked the Academy of Military Medical Sciences’ European patent on the use of remdesivir to treat COVID-19, finding the claimed invention lacked inventive step because prior art published just ten days before the priority date already identified remdesivir a

Unified Patent Court, Court of Appeal (Luxembourg)
Uncategorized

Adobe, OpenAI & Others v. KeeeX — UPC Court of Appeal Sets Clear Limits on Long-Arm Jurisdiction Over Non-Contracting States

In a case marking OpenAI’s first significant patent lawsuit in Europe, the UPC Court of Appeal overturned the Paris Local Division and held that the UPC has no jurisdiction to adjudicate patent infringement in non-UPC contracting states like the UK, Switzerland, and Spain.

Court of Justice of the European Union (CJEU)
Uncategorized

GEMA v. VHC 2 Seniorenresidenz — CJEU Rules Retirement Home TV/Radio Retransmission Is Not a “Communication to the Public”

The CJEU held that a retirement home’s retransmission of satellite TV and radio signals to residents’ rooms via internal cable does not constitute a ‘communication to the public’ under EU copyright law, because residents are not a ‘new public’ beyond the original

Court of Justice of the European Union (CJEU)
Uncategorized

M.M. Ristorazione v. Villa Ramazzini (CJEU C-132/25) — EU Court Rules Provisional IP Measures Cannot Persist Indefinitely Without Substantive Proceedings

The Court of Justice of the European Union ruled that Article 9(5) of the IP Enforcement Directive precludes national laws that allow provisional trademark measures to remain in force indefinitely when the rights-holder fails to file substantive proceedings within the mandatory deadline.

Unified Patent Court, Mannheim Local Division
Uncategorized

Nokia v. Geely — UPC Mannheim Issues Landmark Anti-Anti-Suit Injunction With €50 Million Penalty in Global SEP Dispute

The UPC Mannheim Local Division issued an ex parte anti-anti-suit injunction ordering Geely to withdraw its Chinese interim licence application or face fines up to €50 million, in a landmark ruling reinforcing that the right to enforce a patent includes its procedural enforceability.

Court of Justice of the European Union (Grand Chamber)
Uncategorized

CG & YN v. Pelham GmbH (Pelham II) — CJEU Defines ‘Pastiche’ Exception for Music Sampling Under EU Copyright Law

The CJEU Grand Chamber ruled that EU copyright’s ‘pastiche’ exception is not a catch-all defense but covers creations that use characteristic copyrighted elements to engage in recognizable artistic dialogue with existing works — a landmark holding for music sampling, remix culture,

Court of Justice of the European Union (Grand Chamber)
Uncategorized

Pelham v. Hütter (Pelham II) — CJEU Grand Chamber Defines ‘Pastiche’ Exception for Music Sampling, Requires ‘Recognizable Artistic Dialogue’

In the latest chapter of the 25-year Kraftwerk sampling dispute, the CJEU Grand Chamber held that the copyright ‘pastiche’ exception is not a catch-all but requires overt, recognizable artistic dialogue with the source work — with major implications for sampling, remix culture, and AI-ge

Unified Patent Court, Court of Appeal
Uncategorized

UPC Court of Appeal — Amgen v. Sanofi & Regeneron (UPC_CoA_528/2024) — Sets Out the UPC’s Inventive-Step Framework: Realistic Starting Point, Objective Problem, “Would Not Could”

In a same-day companion ruling to Meril v. Edwards, the UPC Court of Appeal articulated a comprehensive inventive-step framework: identify the objective problem from the perspective of the skilled person, choose a realistic starting point in the prior art, and assess whether the skilled person &#821

Unified Patent Court, Court of Appeal
Uncategorized

Meril v. Edwards Lifesciences (UPC_CoA_464/2024 et al., EP 3 646 825) — UPC Court of Appeal Same-Day Companion to Amgen v. Sanofi: “Same Parties” Test, Embodiment Coverage, and Non-Obvious-Alternative Inventive Step

Same-day companion to Amgen v. Sanofi/Regeneron, the UPC Court of Appeal in Meril v. Edwards held that the ‘same parties’ test under Art. 33(4) UPCA looks to identity of interests; that disclosed embodiments are generally covered by the patent claims unless the specification clearly teac

Unified Patent Court, Court of Appeal — Panel 2
Uncategorized

UPC Court of Appeal — Boehringer Ingelheim v. Zentiva (UPC_CoA_446/2025) — Marketing Authorisation Alone Does Not Imminent-Infringe, But Completion of National Pricing & Reimbursement Procedures Can

The UPC Court of Appeal set out a workable test for when a generic pharmaceutical’s pre-launch activity creates an imminent threat of infringement supporting provisional measures: a bare marketing authorisation does not, but completion of national health-technology-assessment, pricing, and rei

Scroll to Top